Journal of Ophthalmology

Ocular Surface Disease: Advances in Diagnostics and Therapeutics


Status
Published

1Saarland University Medical Center, Homburg, Germany

2Queen Victoria Hospital NHS Foundation Trust, East Grinstead, UK

3University of Miami, Coral Gables, USA


Ocular Surface Disease: Advances in Diagnostics and Therapeutics

Description

Ocular surface disease includes a variety of complex pathologies such as Stevens-Johnson syndrome, mucous membrane pemphigoid, limbal stem cell insufficiency, dry eye disease, ocular graft-versus-host disease, and many others with the common clinical feature of ocular surface failure, resulting in inflammatory and infectious complications with potentially severe visual loss. Early diagnosis and effective treatment of ocular surface disease-related conditions require high level of expertise and are often extremely challenging posing difficult dilemmas to clinicians.

The current issue aims to attract original research studies, of both experimental and clinical interests, on modern diagnostics and therapeutic approaches on ocular surface disease-related pathologies, adding a valuable contribution to our existing knowledge in the field. We especially welcome submissions related to novel diagnostic tests and new therapeutic strategies or new surgical techniques, in the hope that they will facilitate more effective diagnosis and improve our treatment outcomes. Moreover, we would encourage comprehensive review articles which describe the current state of the art, increasing our understanding of ocular surface disease.

Potential topics include but are not limited to the following:

  • Mucous membrane pemphigoid
  • Ocular cicatricial disease
  • Stevens-Johnson syndrome
  • Dry eye disease
  • Meibomian gland dysfunction
  • Limbal stem cell insufficiency
  • Ocular graft-versus-host disease
  • Neuropathic cornea
  • Recurrent corneal erosion syndrome
  • Corneal dystrophies and degenerations

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 6342130
  • - Editorial

Ocular Surface Disease: Advances in Diagnostics and Therapeutics

Zisis Gatzioufas | Samer Hamada | Sotiria Palioura
  • Special Issue
  • - Volume 2018
  • - Article ID 3538764
  • - Clinical Study

Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer

Dominika Wróbel-Dudzińska | Jorge Alio | ... | Tomasz Żarnowski
  • Special Issue
  • - Volume 2018
  • - Article ID 7314308
  • - Research Article

Psychological Aspects and Depression in Patients with Symptomatic Keratoconus

Marilita M. Moschos | Nikolaos S. Gouliopoulos | ... | Irini Chatziralli
  • Special Issue
  • - Volume 2018
  • - Article ID 9580292
  • - Research Article

Total Penetrating Keratoplasty: Indications, Therapeutic Approach, and Long-Term Follow-Up

Katarzyna Krysik | Ewa Wroblewska-Czajka | ... | Dariusz Dobrowolski
  • Special Issue
  • - Volume 2018
  • - Article ID 5315137
  • - Research Article

In Vivo Confocal Microscopic Observations of Vortex Keratopathy in Patients with Amiodarone-Induced Keratopathy and Fabry Disease

Yasuhito Ikegawa | Atsushi Shiraishi | ... | Yuichi Ohashi
  • Special Issue
  • - Volume 2018
  • - Article ID 1319628
  • - Clinical Study

Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients

Wissam Georges El Hajj Moussa | Rebecca Georges Farhat | ... | Georges Georges Azar
  • Special Issue
  • - Volume 2018
  • - Article ID 4324590
  • - Clinical Study

Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial

R. M. Hazarbassanov | N. G. T. Queiroz-Hazarbassanov | ... | J. A. P. Gomes
  • Special Issue
  • - Volume 2018
  • - Article ID 1875627
  • - Research Article

Corneal Debridement Combined with Intrastromal Voriconazole for Recalcitrant Fungal Keratitis

Yajie Sun | Zhuo Sun | ... | Guohua Deng
Journal of Ophthalmology
 Journal metrics
Acceptance rate36%
Submission to final decision74 days
Acceptance to publication31 days
CiteScore2.800
Impact Factor1.447
 Submit